"For those with a history of previous medical or surgical treatment for their endometriosis, Relugolix CT is an alternative ...

People with endometriosis could be given a new pill on the NHS which is said to be better than what's currently on offer.

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

The National Health Service (NHS) in England has approved Gedeon Richter’s Ryeqo (relugolix + estradiol + norethisterone), ...

A new combination pill has been given the green light by the National Institute for Health and Care Excellence (Nice) to ...

Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

A new pill that promises to help endometriosis sufferers deal with the chronic disease’s debilitating symptoms was approved ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

Endometriosis causes chronic pain and fatigue when tissue similar to the womb lining grows outside the uterus. With diagnosis often taking up to 9 years, the availability of additional treatment ...

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The first-of-its-kind endometriosis pill provides hope for 1.5 million people in the UK affected by the condition ...